Humira Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Drug: Humira (Adalimumab);   Drug: SB5 (Adalimumab Biosimilar) Sponsors:   Samsung Bioepis Co., Ltd.;   Organon and Co Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2022 Category: Research Source Type: clinical trials

Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Conditions:   Immunoclassification;   Psoriasis Intervention:   Biological: adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
Condition:   Rheumatoid Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab Sponsors:   Leiden University Medical Center;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2022 Category: Research Source Type: clinical trials